Latest filing published 24 Feb 2026 for Inspire Medical Systems, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Timothy P. Herbert, listed as chief executive, appears in our data through filings on Inspire Medical Systems, Inc. shares, published by SEC (Form 4). We count 86 filings; the first trade dates from 7 May 2018 and the latest from 20 February 2026.
In open-market terms, that means 1 purchase worth €4,693 on one side and 58 sales worth €61.1M on the other. Netting one side against the other leaves €61.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants and 11 option exercises.
The newest entry dates from 24 February 2026: a share grant, in Inspire Medical Systems, Inc. The clock since the last published purchase (9 May 2018) now reads 3,086 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations